SCHEMBL10183669

SCHEMBL10183669

O=C1C(N(C(=O)CNc2ccc(F)cc2)c2cccc(F)c2)c2ccccc2N1C1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCKBR P32239 5/20 0.41
▸ CCKAR P32238 2/20 0.41
▸ MAPT P10636 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ OPRM1 P35372 2/20 0.36
▸ OPRK1 P41145 2/20 0.36
▸ OPRL1 P41146 2/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ AGTR2 P50052 1/20 0.34
▸ USP2 O75604 2/20 0.34
▸ IDH1 O75874 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183945 0.92 OPRK1 (0.38) CCKBRCCKARMAPTLMNATP53
SCHEMBL10185847 0.91 MAPT (0.36) CCKBRCCKARMAPTLMNATP53
SCHEMBL10183764 0.89 TP53 (0.34) CCKBRCCKARMAPTLMNATP53
SCHEMBL10185604 0.89 CCKBR (0.36) CCKBRCCKARMAPTLMNATP53
SCHEMBL10183927 0.89 OPRM1 (0.36) CCKBRCCKARMAPTLMNATP53
SCHEMBL10185589 0.89 TP53 (0.34) CCKBRCCKARMAPTLMNATP53
SCHEMBL10183782 0.89 OPRM1 (0.40) CCKBRCCKARMAPTLMNATP53
SCHEMBL10183654 0.88 IDH1 (0.38) CCKBRCCKARMAPTLMNATP53
SCHEMBL10185569 0.87 MAPT (0.34) CCKBRCCKARMAPTLMNATP53
SCHEMBL10184157 0.87 MAPT (0.38) MAPTLMNATP53OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback